Definition
AI drug discovery applies machine learning and computational simulation to design drug candidates — including antigens, proteins, and small molecules — reducing reliance on trial-and-error wet-lab screening.
Key Points
- 2026 milestone: Cambridge/diosynvax completed first human trial of vaccine whose active component was fully AI-designed (Sarbeco universal coronavirus vaccine)
- Method: AI-designed “super-antigen” targeting conserved viral features across a virus family
- Phase 1 (39 volunteers): safe; modest cross-reactive antibodies; efficacy unproven
- Delivery: DNA vaccine via needle-free microfluidic jet
- Broader pipeline: flu and Ebola vaccine designs in development
Phase 1 safety ≠ clinical efficacy. Avoid "AI cures pandemics" hype framing.